The opportunity: Pennsylvania recently expanded Medicaid coverage to include obesity drugsthe state spent $298 million on GLP-1s in 2024, second only to California
ADA Standards of Care annual guidelines address: Prevention, screening, and treatment standards Diabetes complications and comorbidities Preventing or delaying type 2 diabetes (T2D) Important Tip: Save the date for the ADAs 85 th Scientific Sessions in Chicago, IL, June 2023, 2025, at the McCormick Place Convention Center
This study indicated that liraglutide reduced cardiovascular incidents, such as heart attacks and strokes, by 13% in comparison to placebo
Ongoing research includes: long-term pancreatic studies thyroid cancer surveillance 5-year cardiovascular follow-ups GI motility research safety monitoring for chronic users registries for severe GLP-1 complications FDA GLP-1 Warnings When to Call a Doctor Immediately Seek medical attention if you experience: severe abdominal pain persistent vomiting dehydration rapid weight loss inability to eat jaundice sharp back or flank pain little or no urine output These may indicate long-term GI damage, pancreatitis, or kidney injury
Obesity and diabetes
Once you're assigned a provider, they approve / dissaprove you, then you pay for the medication